ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Acurx Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.14+0.04 (+3.64%)
Close on Oct 19, 2026
- Market cap
- $4.86M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Acurx Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 16, 2026 | Sep 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2025 | Sep 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 16, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 20, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 17, 2025 | May 29, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 9, 2024 | Aug 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2024 | Mar 18, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 15, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 15, 2023 | Nov 15, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2023 | Nov 14, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 13, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2023 | Nov 3, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2023 | Oct 2, 2023 | SEC EDGAR |